- Home
- VIR vs BOE Comparison
VIR vs BOE Comparison
Compare VIR & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- BOE
- Stock Information
- Founded
- VIR 2016
- BOE 2005
- Country
- VIR United States
- BOE United States
- Employees
- VIR N/A
- BOE N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- BOE Trusts Except Educational Religious and Charitable
- Sector
- VIR Health Care
- BOE Finance
- Exchange
- VIR Nasdaq
- BOE Nasdaq
- Market Cap
- VIR 724.1M
- BOE 634.0M
- IPO Year
- VIR 2019
- BOE N/A
- Fundamental
- Price
- VIR $5.57
- BOE $10.54
- Analyst Decision
- VIR Buy
- BOE
- Analyst Count
- VIR 6
- BOE 0
- Target Price
- VIR $35.67
- BOE N/A
- AVG Volume (30 Days)
- VIR 1.4M
- BOE 166.1K
- Earning Date
- VIR 05-01-2025
- BOE 01-01-0001
- Dividend Yield
- VIR N/A
- BOE 7.30%
- EPS Growth
- VIR N/A
- BOE N/A
- EPS
- VIR N/A
- BOE N/A
- Revenue
- VIR $74,205,000.00
- BOE N/A
- Revenue This Year
- VIR N/A
- BOE N/A
- Revenue Next Year
- VIR $17.69
- BOE N/A
- P/E Ratio
- VIR N/A
- BOE N/A
- Revenue Growth
- VIR N/A
- BOE N/A
- 52 Week Low
- VIR $4.95
- BOE $8.80
- 52 Week High
- VIR $14.45
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- VIR 35.32
- BOE 47.26
- Support Level
- VIR $4.95
- BOE $9.16
- Resistance Level
- VIR $6.02
- BOE $10.46
- Average True Range (ATR)
- VIR 0.48
- BOE 0.29
- MACD
- VIR -0.00
- BOE -0.01
- Stochastic Oscillator
- VIR 29.25
- BOE 73.56
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.